Effects of melatonin-pretreated adipose-derived mesenchymal stem cells (MSC) in an animal model of spinal cord injury
Open Access
- 16 November 2022
- journal article
- research article
- Published by Springer Nature in BMC Neuroscience
- Vol. 23 (1) , 1-12
Abstract
Background: One of the most serious nervous system diseases is spinal cord injury(SCI), which is increasing for various reasons. Although no definitive treatment has yet been identified for SCI, one possible treatment is adipose-derived stem cells(ADSCs). However, a key issue in transplantation is improving cells’ survival and function in the target tissue. Melatonin(MT) hormone with antioxidant properties can prolong cell survival and improve cell function. This study investigates the pre-conditioning of ADSCs with melatonin for enhancing the engraftment and neurological function of rats undergoing SCI. Methods: 42 male Sprague–Dawley rats were divided into six groups, including Control, Sham, Model, Vehicle, and Lesion treatments A and B. After acquiring white adipose tissue, stem cells were evaluated by flow cytometry. SCI was then applied in Model, Vehicle, A, and B groups. Group A and B received ADSCs and ADSCs + melatonin, respectively, 1 week after SCI, but the vehicle received only an intravenous injection for simulation; The other groups were recruited for the behavioral test. Immunohistochemistry(IHC) was used to assess the engraftment and differentiation of ADSCs in the SCI site. Basso, Beattie, and Bresnahan's score was used to evaluate motor function between the six groups. Results: Histological studies and cell count confirmed ADSCs implantation at the injury site, which was higher in the MT-ADSCs (P < 0.001). IHC revealed the differentiation of ADSCs and MT-ADSCs into neurons, astrocytes, and oligodendrocyte lineage cells, which were higher in MT-ADSCs. Functional improvement was observed in SCI + ADSCs and SCI + MT-ADSCs groups. Conclusion: The pre-conditioning of ADSCs with melatonin positively affects engraftment and neuronal differentiation in SCI but does not impact performance improvement compared to the ADSCs.Keywords
Funding Information
- Guilan University of Medical Sciences
This publication has 37 references indexed in Scilit:
- Melatonin enhances neural stem cell differentiation and engraftment by increasing mitochondrial functionJournal of Pineal Research, 2017
- Traumatic Spinal Cord Injury—Repair and RegenerationNeurosurgery, 2017
- Two complementary strategies to improve cell engraftment in mesenchymal stem cell-based therapy: Increasing transplanted cell resistance and increasing tissue receptivityCell Adhesion & Migration, 2016
- Melatonin Pretreatment Enhances the Homing of Bone Marrow-derived Mesenchymal Stem Cells Following Transplantation in a Rat Model of Liver Fibrosis2016
- Melatonin protects ADSCs from ROS and enhances their therapeutic potency in a rat model of myocardial infarctionJournal of Cellular and Molecular Medicine, 2015
- Melatonin pretreatment of human adipose tissue-derived mesenchymal stromal cells enhances their prosurvival and protective effects on human kidney cellsAmerican Journal of Physiology-Renal Physiology, 2015
- Melatonin Pretreatment Improves the Survival and Function of Transplanted Mesenchymal Stem Cells after Focal Cerebral IschemiaCell Transplantation, 2014
- Neuronal Differentiation of Adipose Derived Stem Cells: Progress So FarInternational Journal of Photoenergy, 2014
- Functional effect of mouse embryonic stem cell implantation after spinal cord injuryJournal of Exercise Rehabilitation, 2013
- A Sensitive and Reliable Locomotor Rating Scale for Open Field Testing in RatsJournal of Neurotrauma, 1995